Commercial Services and Supplies
Company Overview of Colorado Bioscience Association
Colorado Bioscience Association (CBSA) is a not-for-profit corporation that provides services and support programs to the bioscience companies in Colorado. The association offers education, advocacy support, technical, and networking programs. It was formerly known as Colorado Biotechnology Association. The association changed its name to Colorado Bioscience Association on following its merger with Colorado Medical Device Association (CMDA) on 10/1/2003. CBSA was founded in 1997 and is based in Aurora, Colorado.
12635 East Montview Boulevard
Aurora, CO 80010
Founded in 1997
Key Executives for Colorado Bioscience Association
Chief Executive Officer and President
Interim Executive Director
Board Secretary and Director
Compensation as of Fiscal Year 2013.
Colorado Bioscience Association Key Developments
Colorado Bioscience Association Announces Board Changes
May 3 13
Derek Cole, President of Investor Relations Advisory Solutions was named Chairperson of the Board of Directors for the Colorado BioScience Association (CBSA) at its 2013 Annual All-Member meeting held at the Omni Interlocken Resort in Broomfield, CO. Joining Cole on the company's Board officer team will be newly appointed Vice Chairperson Mark Spiecker, CEO, Sharklet Technologies; Jim Wilson, Board Treasurer, Partner, Ernst & Young; and Lisa Drake, Board Secretary, Director, Government Affairs, Monsanto. In other action, six new board members were appointed by the company's Board of Directors. Newly appointed CBSA board members include: Brenda Fielding, Executive Vice President, Regulatory and Strategic Development, Clinipace; Scott Larson, Senior Vice President, Legal and General Counsel, Terumo BCT; Brett Lund, Executive Vice President, General Counsel and Secretary, Gevo; Bill Marshall, Ph.D., President, CEO, Co-Founder and Director, miRagen; Chris Myatt, Ph.D., Co-Founder and CEO, MBio Diagnostics Inc.; and Bob Reddy, Director of Global Marketing, Medtronic.
Colorado Bioscience Association Launches its Colorado BioScience Institute; Announces Management Appointments
Jan 7 13
Colorado Bioscience Association is launching the Colorado BioScience Institute on January 7, 2013. The Institute is a 501(c)3 non-profit that Association is establishing to provide educational and workforce programs for teachers, students, bioscience professionals and the broader community. The Institute will create a framework to train the very best young scientists and business entrepreneurs, as well as assist companies with the recruitment, retention and attraction of these future bioscience employees and leaders. The Institute has established these five overarching program areas that are critical to the future of bioscience in Colorado: Teachers—Providing teachers with practical knowledge and experience to enhance their content understanding and classroom practice, especially related to Science, Technology, Engineering and Mathematics (STEM). Professionals—Providing programs for experienced researchers, entrepreneurs, and business leaders to build businesses and advance their careers in the bioscience industries. Workforce Development—Providing classes, trainings programs, internships as a form of workforce recruitment and development. Secondary Students (9-12)—Providing students with opportunities to explore careers in biotechnology and associated industries. Community—Creating broader awareness of the industry’s impact through partnerships with other organizations. The Institute will also provide assistance to patient advocacy and disease-related organizations to help build awareness of their important work in Colorado.
The Colorado BioScience Institute will be led by the Board of Directors: Steve Orndorff, Ph.D., CBSA Board Chair, President and CEO, Ariel Pharmaceuticals, Derek Cole, CBSA Board Vice Chair, Vice President, Investor Relations & Corporate Communications, ARCA Biopharma, Jim Wilson, CBSA Board Treasurer, Partner, Ernst & Young, John Dunning, CBSA Board Secretary, President & CEO, Clarimedix Inc., Mark Spiecker, CBSA Executive Committee, Education, Chief Executive Officer, Sharklet Technologies and Nicole Garneau, Ph.D., CBSA Education Committee, Curator and Chair of the Health Sciences Department at Denver Museum of Nature & Science.
Colorado Bioscience Association Names April Giles as President & CEO
Nov 8 12
April Giles, Executive Vice President of the Colorado BioScience Association (CBSA) for the past two and a half years, has been named President & CEO following an extensive national executive search conducted by an ad hoc committee of the CBSA Board of Directors. Giles replaces Holli Riebel, who resigned in June to accept the Chief Operations Officer position at the Metro Denver Chamber of Commerce. In the interim, Giles had been responsible for the day-to-day operations of the association. Giles joined the CBSA as Director of Operations in 2006 and moved to Vice President, Administration & Operations in 2009 and was promoted to Executive Vice President in 2010.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|